Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by dardanion Sep 12, 2016 4:46pm

167 Views

Post# 25229525

RE:RE:RE:RE:RE:Theralase to Present at Global Investment Conference

" This is one time I think Roger has not over promised."

You heard it first here on Stockhouse. HC has informed Roger who in turn has passed along the information privately to wasagastar that the ITA approval will be handed down the week of Sept 19-23. Then on to 2 months of patient screening. Phew, glad the preliminary work will finally be over next week.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features